Form EFFECT Inhibrx Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 18, 2025 |
| Accession Number: | 0002007919-25-000051 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 25 06 2026] - (CGAML)
- Franklin Templeton Files New Crypto ETFs That Turn Dividends Into Bitcoin While Pepeto Hits $10.3 million in Presale
- Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
